Vikram specialises in due diligences in healthcare and pharma, industrial manufacturing, construction, real estate and IT sectors. He specialises in identifying potential deal breakers, evaluating the impact of accounting, tax and business issues on valuation models, assisting in negotiating due diligence issues and providing inputs into transaction documents.
Vikram's experience spans a cross-section of our clients, both multinational and leading Indian business houses, on both the buy and sell side on Indian and cross border (inbound as well as outbound) transactions. He has been involved in several data rooms, full access due diligences, carve outs, model reviews and supporting negotiations for various transactions in these sectors for large private equity funds and strategic players. Vikram also has considerable sell side experience and has led vendor due diligence and data room management assignments.
Vikram's private equity clients include Temasek, JP Morgan, Carlyle Group, TPG, Actis, Olympus Capital, Goldman Sachs and ICICI Venture. His corporate clients include: The Apollo group, The Sanmar group, i-Flex, TCS, Covansys, Subhiksha, SameGreaves, Star TV, Omnicom, and Carborandum Universal. His recent healthcare and pharmaceutical experiences are:- assisted Apax partners in its investment in the Apollo hospitals; assisted Blackstone in its investment in Emcure pharmaceuticals; assisted Ranbaxy in its acquisition of Terapia; assisted Shasun Chemicals in its acquisition of 2 chemical plants of the Rhodia group of companies in UK.